Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease

Volume: 14, Issue: 4, Pages: e0215033 - e0215033
Published: Apr 19, 2019
Abstract
Epoxyeicosatrienoic acids (EETs) are signaling lipids produced by cytochrome P450 epoxygenation of arachidonic acid, which are metabolized by EPHX2 (epoxide hydrolase 2, alias soluble epoxide hydrolase or sEH). EETs have pleiotropic effects, including anti-inflammatory activity. Using a Connectivity Map (CMAP) approach, we identified an inverse-correlation between an exemplar EPHX2 inhibitor (EPHX2i) compound response and an inflammatory bowel...
Paper Details
Title
Preclinical evaluation of EPHX2 inhibition as a novel treatment for inflammatory bowel disease
Published Date
Apr 19, 2019
Journal
Volume
14
Issue
4
Pages
e0215033 - e0215033
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.